R Stanhope - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

R Stanhope

Showing results (211-220 of 213) with videos related to

Pageof 22

Sort By:

You have reached the last page of results.This site can display upto 213 results.

Mayo Clinic Proceedings|December 1, 1987

Ovarian dysgerminoma: a retrospective analysis of results of treatment, sites of treatment failure, and radiosensitivityS J Buskirk, M F Schray, K C Podratz, et al.

Journal of the National Cancer Institute|October 4, 1989

Cyclophosphamide-cisplatin versus cyclophosphamide-carboplatin in stage III-IV ovarian carcinoma: a comparison of equally myelosuppressive regimensJ H Edmonson, G M McCormack, H S Wieand, et al.

Human Molecular Genetics|January 4, 2001

Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasiaP Q Thomas, M T Dattani, J M Brickman, et al.

Pageof 22

Search research articles

Showing results (211-220 of 213) with videos related to

Sort By:

Pageof 22

You have reached the last page of results.This site can display upto 213 results.

Mayo Clinic Proceedings|December 1, 1987

Ovarian dysgerminoma: a retrospective analysis of results of treatment, sites of treatment failure, and radiosensitivityS J Buskirk, M F Schray, K C Podratz, et al.

Journal of the National Cancer Institute|October 4, 1989

Cyclophosphamide-cisplatin versus cyclophosphamide-carboplatin in stage III-IV ovarian carcinoma: a comparison of equally myelosuppressive regimensJ H Edmonson, G M McCormack, H S Wieand, et al.

Human Molecular Genetics|January 4, 2001

Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasiaP Q Thomas, M T Dattani, J M Brickman, et al.

Pageof 22